Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors
CA 2120370 A1 · Owner: Crucell Holland B.V. · Inventors: Van Beusechem, Victor W.; Valerio, Domenico
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for genetically modifying bone marrow cells of primates comprising isolating bone marrow cells from a primate and by, means of cocultivation, exposing the isolated bone marrow cells to cells that produce a recombinant amphotropic retrovirus with a genome based on a retroviral vector that contains the genetic information to be introduced into the bone marrow cells. Recombinant amphotropic retrovirus-producing cells suitable for use in this, method.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 5, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 5, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 5, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.